Armor Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Armor Investment Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-67	Closed	-$9K	–	166
2022 Q1	$9K	Hold	67	–	–	0.01%	159
2021 Q4	$10K	Sell	67 -19	-22%	-$2.94K	0.01%	148
2021 Q3	$14K	Hold	86	–	–	0.01%	147
2021 Q2	$14K	Hold	86	–	–	0.01%	150
2021 Q1	$13K	Hold	86	–	–	0.01%	147
2020 Q4	$13K	Hold	86	–	–	0.01%	146
2020 Q3	$12K	Hold	86	–	–	0.01%	126
2020 Q2	$12K	Hold	86	–	–	0.01%	124
2020 Q1	$9K	Buy	86 +19	+28%	+$2.19K	0.01%	125
2019 Q4	$8K	Hold	67	–	–	0.01%	145
2019 Q3	$7K	Hold	67	–	–	0.01%	136
2019 Q2	$7K	Hold	67	–	–	0.01%	138
2019 Q1	$7K	Hold	67	–	–	0.01%	142
2018 Q4	$6K	Hold	67	–	–	0.01%	123
2018 Q3	$8K	Buy	+67	New	+$7.89K	0.01%	132

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Armor Investment Advisors's IBB Position: Q2 2022 in Review

Armor Investment Advisors sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 67 shares — an estimated $9K sold.

Armor Investment Advisors first reported a position in IBB in Q3 2018 and held it in 15 quarters. The position peaked at $14K in Q3 2021. 858 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

Armor Investment Advisors reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
Armor Investment Advisors sold 67 iShares Biotechnology ETF shares in Q2 2022, an estimated $9K.
Armor Investment Advisors first reported a position in iShares Biotechnology ETF in Q3 2018 and held it in 15 quarters.
Armor Investment Advisors's iShares Biotechnology ETF position peaked at $14K in Q3 2021.
858 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on Armor Investment Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.